跳至主要内容
临床试验/CTRI/2019/08/020946
CTRI/2019/08/020946尚未招募2 期

Phase II non-randomized open clinical evaluation of Siddha Drug "Naga Chendhooram" for Madhumegam (Type 2 Diabetes Mellitus)- in patients of both gender between age group of 30 to 60 years, attending OPD at AAGHIM attached with GSMC

Government Siddha Medical College1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年4月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Reduction in clinical symptoms

研究概览

简要总结

This is a Non randomised open clinical trial to study the safety and efficacy of siddha drug "Naga Chendhooram". Drug is given 100 mg twice a day for 90 days. Clinical trial is conducted after completion of preclinical toxicity studies. The said drug "Naga Chendhooram" has reference in "Siddha Formulary of india" - part1 . During the study, all the related data will be recorded and documented.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Mandatory Fasting blood glucose-120 to 160 mg/do PP blood glucose- 180 to 280 mg/DL HbA1c- 6.5 to 9% Optional Polyuria Polyphagia Polydipsia Nocturia.

排除标准

  • Insulin dependent Diabetes mellitus Cardiovascular disease Diabetic nephropathy Diabetic retinopathy Pregnant women Lactating mothers Tuberculosis affected individuals HbA1c > 9%.

结局指标

主要结局

Reduction in clinical symptoms

时间窗: 90 days

Reduction in blood sugar and HbA1c level by atleast 20% or to maintain HbA1c level within 7%

时间窗: 90 days

次要结局

  • Secondary outcome is assessed by comparing the safety parameters before and after treatment(90 days)

研究者

发起方
Government Siddha Medical College
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验